Inventor · disambiguated record
Bruno Dombrecht
Also filed as: DOMBRECHT BRUNO
20 granted patents·10 pending applications·85 citations·filing 2011–2023
94Inventor score
Top patents by PatentIndex Score
30 records- 0197US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 0294US11208476B2Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 28, 2021·12 cites·12 claims
- 0392US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 0492US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 0588US11840566B2Methods of treating asthma with polypeptides targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 12, 2023·1 cites·18 claims
- 0688US9573992B2Serum albumin binding proteinsDOMBRECHT BRUNO·Filed 2012·Granted Feb 21, 2017·13 cites·20 claims
- 0787US9328174B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2013·Granted May 3, 2016·8 cites·11 claims
- 0885US12006352B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Jun 11, 2024·1 cites·6 claims
- 0985US8591896B2Chemokine receptor binding polypeptidesBRADLEY MICHELLE·Filed 2011·Granted Nov 26, 2013·6 cites·29 claims
- 1085US2023242620A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2023·Application pending·0 cites
- 1181US11644471B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2013·Granted May 9, 2023·2 cites·9 claims
- 1280US10072098B2Pseudomonas aeruginosa PCRV binding single variable domain antibodiesABLYNX NV·Filed 2013·Granted Sep 11, 2018·5 cites·25 claims
- 1378US9120855B2Biologic compounds directed against death receptor 5CROMIE KAREN·Filed 2011·Granted Sep 1, 2015·7 cites·17 claims
- 1474US12492248B2Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 9, 2025·0 cites·17 claims
- 1574US12384840B2Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Aug 12, 2025·0 cites·16 claims
- 1671US9688763B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2015·Granted Jun 27, 2017·1 cites·10 claims
- 1771US9127067B2Methods of treatment using chemokine receptor binding polypeptidesBRADLEY MICHELLE·Filed 2013·Granted Sep 8, 2015·1 cites·7 claims
- 1867US2021188965A1Polypeptides comprising immunoglobulin single variable domains targeting il-13 and tslpABLYNX NV·Filed 2020·Application pending·0 cites
- 1966US2018355031A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2018·Application pending·0 cites
- 2062US2018009888A9Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsBAUMEISTER JUDITH·Filed 2012·Application pending·0 cites
- 2158US11312788B2Pseudomonas aeruginosa PcrV binding single variable domain antibodiesABLYNX NV·Filed 2018·Granted Apr 26, 2022·0 cites·18 claims
- 2257US10174118B2Nucleic acids encoding chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2015·Granted Jan 8, 2019·0 cites·8 claims
- 2356US12509522B2Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40LABLYNX NV·Filed 2021·Granted Dec 30, 2025·0 cites·20 claims
- 2454US11466089B2Chemokine receptor binding polypeptidesABLYNX NV·Filed 2017·Granted Oct 11, 2022·0 cites·10 claims
- 2553US2024052045A1Murine cross-reactive human ccr8 bindersVIB VZW·Filed 2021·Application pending·0 cites
- 2653US2024052044A1Non-blocking human ccr8 bindersVIB VZW·Filed 2021·Application pending·0 cites
- 2753US2024018248A1An ltbr agonist in combination therapy against cancerVIB VZW·Filed 2021·Application pending·0 cites
- 2851US2024076391A1Human ccr8 bindersONCURIOUS NV·Filed 2021·Application pending·0 cites
- 2951US2015259426A1Biologic compoundsNOVARTIS AG·Filed 2014·Application pending·0 cites
- 3050US2017210789A1Serum albumin binding proteinsABLYNX NV·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruno Dombrecht files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →